| Literature DB >> 26446298 |
Brian D Wright1, Michael C Deblock1, Patrick O Wagers1, Ernest Duah1, Nikki K Robishaw1, Kerri L Shelton1, Marie R Southerland1, Michael A DeBord1, Kortney M Kersten1, Lucas J McDonald1, Jason A Stiel1, Matthew J Panzner1, Claire A Tessier1, Sailaja Paruchuri1, Wiley J Youngs1.
Abstract
The anti-tumor activity of imidazolium salts is highly dependent upon the substituents on the nitrogen atoms of the imidazolium cation. We have synthesized and characterized a series of naphthalene-substituted imidazolium salts and tested them against a variety of non-smallcell lung cancer cell lines. Several of these complexes displayed anticancer activity comparable to cisplatin. These compounds induced apoptosis in the NCI-H460 cell line as determined by Annexin V staining, caspase-3, and PARP cleavage. These results strongly suggest that this class of compounds can serve as potent chemotherapeutic agents.Entities:
Keywords: Anti-tumor; Anticancer; Apoptosis; Imidazolium cation; Imidazolium salt
Year: 2015 PMID: 26446298 PMCID: PMC4593509 DOI: 10.1007/s00044-015-1330-z
Source DB: PubMed Journal: Med Chem Res ISSN: 1054-2523 Impact factor: 1.965